As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend.
US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.
Uploaded by:
Rediff Video Desk
on Wed, 10 Sep 2025 12:57:42 +0530
Views: 7
Tags: How India's pharma cos plan to tackle steep US tariffs
